Ion Beam Applications
Company type | Public |
---|---|
Euronext: IBAB | |
Industry | Medical technology |
Founded | 1986 |
Founder | Yves Jongen |
Headquarters | , |
Area served | Worldwide |
Key people | Olivier Legrain (CEO) |
Website | iba-worldwide |
IBA (Ion Beam Applications SA) is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain (UCLouvain) and became a university spin-off. It employs about 1500 people in 40 locations.[1] The company developed cyclotrons and integrated proton therapy centers is active in the field of proton therapy, dosimetry, radiopharmacy solutions and industrial sterilisation.[2]
IBA installed its first proton therapy equipment for Boston's Massachusetts General Hospital in 2001,[3] and for Philadelphia's Penn Hospital in 2009.[4]
It supplied equipment and services to Proton Partners International which was developing three proton beam therapy centers in the United Kingdom.[5][6]
In 2017, IBA invested €16 million in the construction of a new logistics and production center in Louvain-la-Neuve.[7]
References
[edit]- ^ "IBA SA - basic data - update following capital increase dated 15 December 2016". Yahoo Finance. 15 December 2016. Retrieved 24 December 2016.
- ^ "Ion Beam Applications: IBA". Healthcare Belgium. Retrieved 24 December 2016.
- ^ Pearson, Emma; Kleeven, Willem; Nuttens, Vincent; Zaremba, Simon; Van de Walle, Jarno; Forton, Eric; Choo, Robin; Jongen, Yves (2016), Rath, Arabinda Kumar; Sahoo, Narayan (eds.), "Development of Cyclotrons for Proton and Particle Therapy", Particle Radiotherapy, New Delhi: Springer India, pp. 21–35, doi:10.1007/978-81-322-2622-2_3, ISBN 978-81-322-2621-5, retrieved 2022-06-26
- ^ Langreth, David Whelan and Robert (2009-02-26). "The $150 Million Zapper". Forbes. Retrieved 2017-07-30.
- ^ "BRIEF-Ion Beam Applications signs two contracts with Proton Partners International". Reuters. 13 December 2016. Retrieved 24 December 2016.
- ^ "Proton Partners acquires Blue Phantom2 data acquisition system to support innovative cancer treatment". News medical. 9 December 2016. Retrieved 24 December 2016.
- ^ "Un nouveau chapitre pour IBA à Louvain-la-Neuve". Le Soir (in French). 2017-07-11. Retrieved 2022-08-28.